Status:
COMPLETED
Vitamin D3 Supplementation in Pediatric IBD: Weely vs Daily Dosing Regimens
Lead Sponsor:
Nemours Children's Clinic
Collaborating Sponsors:
NASPGHAN Foundation
Conditions:
Inflammatory Bowel Disease (IBD)
Eligibility:
All Genders
5-17 years
Brief Summary
The purpose of this prospecitve randomized controlled trial is to compare effectiveness and patient/family adherence of weekly or daily Vitamin D-3 dosing regimens in children with Inflammatory Bowel ...
Eligibility Criteria
Inclusion
- Subjects aged 5 to 17 years with a diagnosis of Inflammatory Bowel Disease, who have a 25(OH)D level below 30 ng/ml within 2 weeks of enrollment
- Subject/family must be able and willing to take oral medications, complete a 3 day dietary record, and return for 8 week concluding visit or clinicl visit
Exclusion
- Subjects will not be eligible if they are intolerant of vitamin supplementation or any ingredients in the chosen supplment, are unable or unwilling to take oral supplements, or are on specific medical therapy for diminished bone mineral density
- Children with parathryoid disease, granulomatous disorders or William's syndrome will also be excluded from the study
Key Trial Info
Start Date :
November 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02256605
Start Date
November 1 2013
End Date
May 1 2015
Last Update
May 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nemours Children's Clinic
Jacksonville, Florida, United States, 32207